
Cybin Secures $175 Million in Funding from Top Healthcare Investors to Advance Mental Health Therapeutics
Cybin Inc. has closed a $175 million registered direct offering with participation from leading healthcare investors, providing substantial capital to advance its Phase 3 clinical programs for novel mental health treatments.
Read full story

























